Abstract
AbstractbackgroundIn the current global monkeypox outbreak, many jurisdictions have been faced with limited vaccine supply, motivating interest in efficient allocation. We sought to explore optimal vaccine allocation between two linked transmission networks over a short-term time horizon, across a range of epidemic conditions.methodsWe constructed a deterministic compartmental sveir model of monkeypox transmission. We parameterized the model to reflect two representative, weakly connected gbmsm sexual networks (cities) in Ontario. We simulated roll-out of 5000 vaccine doses over 15 days, starting 60 days after epidemic seeding with 10 imported cases. Within this model, we varied: the relative city (network) sizes, epidemic potentials (R0), between-city mixing, and distribution of imported/seed cases between cities. In each context (combination of varied factors), we then identified the “optimal” allocation of doses between cities — resulting in the fewest cumulative infections by day 120.resultsUnder our modelling assumptions, we found that a fixed supply of vaccines could generally avert more infections over short-term time horizons when prioritized to: a larger transmission network, a network with more initial infections, and/or a network with greater R0. Greater between-city mixing decreased the influence of initial seed cases, and increased the influence of city R0 on optimal allocation. Under mixed conditions (e.g. fewer seed cases but greater R0), optimal allocation saw doses shared between cities, suggesting that proximity-based and risk-based vaccine prioritization can work in combination to minimize transmission.interpretationPrioritization of limited vaccine supply based on network-level risk factors can help minimize transmission during an emerging epidemic. Such prioritization should be grounded in an understanding of context-specific drivers of risk, and should acknowledge the potential connectedness of multiple transmission networks.
Publisher
Cold Spring Harbor Laboratory
Reference53 articles.
1. Public Health Agency of Canada. Monkeypox epidemiology update. Aug. 2022. url: https://health-infobase.canada.ca/monkeypox/.
2. Public Health Agency of Canada. Interim guidance on the use of Imvamune in the context of monkeypox out-breaks in Canada. June 2022. url: https://www.canada.ca/content/dam/phac-aspc/documents/services/immunization/national-advisory-committee-on-immunization-naci/guidance-imvamune-monkeypox/guidance-imvamune-monkeypox-en.pdf.
3. Toronto Public Health. Monkeypox Vaccine Fact Sheet. Aug. 2022. url: https://www.toronto.ca/wp-content/uploads/2022/07/97ef-MonkeypoxVaccineFactSheet.pdf.
4. Geoffrey Garnett. “Role of herd immunity in determining the effect of vaccines against sexually transmitted disease”. In: Journal of Infectious Diseases 191.S1 (Jan. 2005). url: https://doi.org/10.1086/425271.
5. Sharmistha Mishra et al. “A Vaccination Strategy for Ontario COVID-19 Hotspots and Essential Workers”. In: Science Briefs of the Ontario COVID-19 Science Advisory Table 2.26 (2021). url: https://doi.org/10.47326/ocsat.2021.02.26.1.0.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献